{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:03:50Z","timestamp":1785423830518,"version":"3.56.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["NO.2022CFB328"],"award-info":[{"award-number":["NO.2022CFB328"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03598-y","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T14:01:30Z","timestamp":1721484090000},"page":"612-629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transcriptomic analysis of Paraoxonase 1 expression in hepatocellular carcinoma and its potential impact on tumor immunity"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4305-9744","authenticated-orcid":false,"given":"Linhuan","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,20]]},"reference":[{"key":"3598_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112798","author":"E Chakraborty","year":"2022","unstructured":"Chakraborty E, Sarkar D. Emerging therapies for hepatocellular carcinoma (HCC)[J]. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14112798.","journal-title":"Cancers"},{"issue":"1","key":"3598_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin. 2020;70(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21590.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3598_CR3","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1038\/s41467-020-18311-0","volume":"11","author":"N Sun","year":"2020","unstructured":"Sun N, Lee YT, Zhang RY, et al. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring[J]. Nat Commun. 2020;11(1):4489. https:\/\/doi.org\/10.1038\/s41467-020-18311-0.","journal-title":"Nat Commun"},{"key":"3598_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113828","author":"TGJ Derks","year":"2021","unstructured":"Derks TGJ, Rodriguez-Buritica DF, Ahmad A, et al. Glycogen storage disease type Ia: current management options, burden and unmet needs[J]. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13113828.","journal-title":"Nutrients"},{"issue":"1","key":"3598_CR5","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.3346\/jkms.2020.35.e5","volume":"35","author":"HJ Jang","year":"2020","unstructured":"Jang HJ, Yang HR, Ko JS, et al. Development of hepatocellular carcinoma in patients with glycogen storage disease: a single center retrospective study[J]. J Korean Med Sci. 2020;35(1):e5. https:\/\/doi.org\/10.3346\/jkms.2020.35.e5.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"3598_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2019.11.061","volume":"522","author":"JH Cho","year":"2020","unstructured":"Cho JH, Lee YM, Bae SH, et al. Activation of tumor-promoting pathways implicated in hepatocellular adenoma\/carcinoma, a long-term complication of glycogen storage disease type Ia[J]. Biochem Biophys Res Commun. 2020;522(1):1\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2019.11.061.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"3598_CR7","first-page":"653","volume":"26","author":"CL Kuo","year":"1998","unstructured":"Kuo CL, la Du BN. Calcium binding by human and rabbit serum Paraoxonases. Structural stability and enzymatic activity[J]. Drug Metab Dispos. 1998;26(7):653\u201360.","journal-title":"Drug Metab Dispos"},{"key":"3598_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097764","author":"H Jakubowski","year":"2023","unstructured":"Jakubowski H. Proteomic exploration of Paraoxonase 1 function in health and disease[J]. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24097764.","journal-title":"Int J Mol Sci"},{"key":"3598_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20164049","author":"MJ Meneses","year":"2019","unstructured":"Meneses MJ, Silvestre R, Sousa-Lima I, et al. Paraoxonase-1 as a regulator of glucose and lipid homeostasis: impact on the onset and progression of metabolic disorders[J]. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20164049.","journal-title":"Int J Mol Sci"},{"key":"3598_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1476-511X-9-46","volume":"9","author":"J Marsillach","year":"2010","unstructured":"Marsillach J, Aragones G, Mackness B, et al. Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment[J]. Lipids Health Dis. 2010;9:46. https:\/\/doi.org\/10.1186\/1476-511X-9-46.","journal-title":"Lipids Health Dis"},{"issue":"9","key":"3598_CR11","doi-asserted-by":"publisher","first-page":"e46234","DOI":"10.7759\/cureus.46234","volume":"15","author":"JD Bade","year":"2023","unstructured":"Bade JD, Veeramalla V, Naidu MBR, et al. Serum activities of Paraoxonase 1 (PON1) in predicting liver damage among patients diagnosed with hepatocellular carcinoma: a case-control study[J]. Cureus. 2023;15(9):e46234. https:\/\/doi.org\/10.7759\/cureus.46234.","journal-title":"Cureus"},{"key":"3598_CR12","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, et al. ROS and the DNA damage response in cancer[J]. Redox Biol. 2019;25:101084. https:\/\/doi.org\/10.1016\/j.redox.2018.101084.","journal-title":"Redox Biol"},{"key":"3598_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cells10081901","author":"HY Lee","year":"2021","unstructured":"Lee HY, Nga HT, Tian J, et al. Mitochondrial metabolic signatures in hepatocellular carcinoma[J]. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10081901.","journal-title":"Cells"},{"issue":"2","key":"3598_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, di Donato M, Pezone A, et al. ROS in cancer therapy: the bright side of the moon[J]. Exp Mol Med. 2020;52(2):192\u2013203. https:\/\/doi.org\/10.1038\/s12276-020-0384-2.","journal-title":"Exp Mol Med"},{"issue":"5","key":"3598_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumor development and progression[J]. Nat Rev Cancer. 2022;22(5):280\u201397. https:\/\/doi.org\/10.1038\/s41568-021-00435-0.","journal-title":"Nat Rev Cancer"},{"key":"3598_CR16","doi-asserted-by":"publisher","first-page":"109699","DOI":"10.1016\/j.abb.2023.109699","volume":"744","author":"L Xing","year":"2023","unstructured":"Xing L, Tang Y, Li L, et al. ROS in hepatocellular carcinoma: what we know[J]. Arch Biochem Biophys. 2023;744:109699. https:\/\/doi.org\/10.1016\/j.abb.2023.109699.","journal-title":"Arch Biochem Biophys"},{"issue":"10","key":"3598_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management[J]. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3598_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fendo.2019.00137","volume":"10","author":"P Mancuso","year":"2019","unstructured":"Mancuso P, Bouchard B. The impact of aging on adipose function and adipokine synthesis[J]. Front Endocrinol. 2019;10:137. https:\/\/doi.org\/10.3389\/fendo.2019.00137.","journal-title":"Front Endocrinol"},{"issue":"1","key":"3598_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.immuni.2022.11.013","volume":"56","author":"X Wang","year":"2023","unstructured":"Wang X, He Q, Zhou C, et al. Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development[J]. Immunity. 2023;56(1):58\u201377. https:\/\/doi.org\/10.1016\/j.immuni.2022.11.013.","journal-title":"Immunity"},{"issue":"12","key":"3598_CR20","doi-asserted-by":"publisher","first-page":"e13512","DOI":"10.1111\/acel.13512","volume":"20","author":"S Mohammed","year":"2021","unstructured":"Mohammed S, Thadathil N, Selvarani R, et al. Necroptosis contributes to chronic inflammation and fibrosis in aging liver[J]. Aging Cell. 2021;20(12):e13512. https:\/\/doi.org\/10.1111\/acel.13512.","journal-title":"Aging Cell"},{"key":"3598_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.freeradbiomed.2020.12.449","volume":"164","author":"S Mohammed","year":"2021","unstructured":"Mohammed S, Nicklas EH, Thadathil N, et al. Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress[J]. Free Radic Biol Med. 2021;164:315\u201328. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.12.449.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"3598_CR22","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.21037\/jgo-22-1143","volume":"14","author":"X Feng","year":"2023","unstructured":"Feng X, Chen W, Tao R, et al. Prognostic impact of portal area inflammation on intrahepatic cholangiocarcinoma patients without lymph node metastasis[J]. J Gastrointest Oncol. 2023;14(5):2229\u201342. https:\/\/doi.org\/10.21037\/jgo-22-1143.","journal-title":"J Gastrointest Oncol"},{"issue":"11","key":"3598_CR23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/15384101.2021.1922806","volume":"20","author":"N Barnaba","year":"2021","unstructured":"Barnaba N, Larocque JR. Targeting cell cycle regulation via the G2-M checkpoint for synthetic lethality in melanoma[J]. Cell Cycle. 2021;20(11):1041\u201351. https:\/\/doi.org\/10.1080\/15384101.2021.1922806.","journal-title":"Cell Cycle"},{"key":"3598_CR24","doi-asserted-by":"publisher","first-page":"103448","DOI":"10.1016\/j.dnarep.2023.103448","volume":"123","author":"MA Zolotovskaia","year":"2023","unstructured":"Zolotovskaia MA, Modestov AA, Suntsova MV, et al. Pan-cancer antagonistic inhibition pattern of ATM-driven G2\/M checkpoint pathway vs other DNA repair pathways[J]. DNA Repair. 2023;123:103448. https:\/\/doi.org\/10.1016\/j.dnarep.2023.103448.","journal-title":"DNA Repair"},{"issue":"2","key":"3598_CR25","doi-asserted-by":"publisher","first-page":"111475","DOI":"10.1016\/j.celrep.2022.111475","volume":"41","author":"L Donker","year":"2022","unstructured":"Donker L, Houtekamer R, Vliem M, et al. A mechanical G2 checkpoint controls epithelial cell division through E-cadherin-mediated regulation of Wee1-Cdk1[J]. Cell Rep. 2022;41(2):111475. https:\/\/doi.org\/10.1016\/j.celrep.2022.111475.","journal-title":"Cell Rep"},{"key":"3598_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163846","author":"BD Humphreys","year":"2022","unstructured":"Humphreys BD. Decoupling dedifferentiation and G2\/M arrest in kidney fibrosis[J]. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI163846.","journal-title":"J Clin Invest"},{"issue":"1","key":"3598_CR27","doi-asserted-by":"publisher","first-page":"6502","DOI":"10.1038\/s41467-022-34287-5","volume":"13","author":"P Wang","year":"2022","unstructured":"Wang P, Huang Z, Peng Y, et al. Circular RNA circBNC2 inhibits epithelial cell G2-M arrest to prevent fibrotic maladaptive repair[J]. Nat Commun. 2022;13(1):6502. https:\/\/doi.org\/10.1038\/s41467-022-34287-5.","journal-title":"Nat Commun"},{"issue":"1","key":"3598_CR28","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1038\/s41467-023-38771-4","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Yang Y, Yang F, et al. HDAC9-mediated epithelial cell cycle arrest in G2\/M contributes to kidney fibrosis in male mice[J]. Nat Commun. 2023;14(1):3007. https:\/\/doi.org\/10.1038\/s41467-023-38771-4.","journal-title":"Nat Commun"},{"issue":"4","key":"3598_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1158\/1535-7163.MCT-21-0604","volume":"21","author":"AP Lombard","year":"2022","unstructured":"Lombard AP, Armstrong CM, D\u2019Abronzo LS, et al. Olaparib-induced senescence is bypassed through G2-M checkpoint override in olaparib-resistant prostate cancer[J]. Mol Cancer Ther. 2022;21(4):677\u201385. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0604.","journal-title":"Mol Cancer Ther"},{"key":"3598_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111639","author":"EJ Sun","year":"2021","unstructured":"Sun EJ, Wankell M, Palamuthusingam P, et al. Targeting the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma[J]. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9111639.","journal-title":"Biomedicines"},{"key":"3598_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032652","author":"LY Tian","year":"2023","unstructured":"Tian LY, Smit DJ, Jucker M. The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism[J]. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032652.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3598_CR32","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","volume":"32","author":"Y Guri","year":"2017","unstructured":"Guri Y, Colombi M, Dazert E, et al. mTORC2 promotes tumorigenesis via lipid synthesis[J]. Cancer Cell. 2017;32(6):807\u201323. https:\/\/doi.org\/10.1016\/j.ccell.2017.11.011.","journal-title":"Cancer Cell"},{"issue":"16","key":"3598_CR33","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1038\/onc.2016.363","volume":"36","author":"LC Kim","year":"2017","unstructured":"Kim LC, Cook RS, Chen J. mTORC1 and mTORC2 in cancer and the tumor microenvironment[J]. Oncogene. 2017;36(16):2191\u2013201. https:\/\/doi.org\/10.1038\/onc.2016.363.","journal-title":"Oncogene"},{"key":"3598_CR34","doi-asserted-by":"publisher","first-page":"100790","DOI":"10.1016\/j.drup.2021.100790","volume":"59","author":"P Icard","year":"2021","unstructured":"Icard P, Simula L, Wu Z, et al. Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?[J]. Drug Resist Updat. 2021;59:100790. https:\/\/doi.org\/10.1016\/j.drup.2021.100790.","journal-title":"Drug Resist Updat"},{"key":"3598_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169196","author":"J Feng","year":"2022","unstructured":"Feng J, Qiu S, Zhou S, et al. mTOR: a potential new target in nonalcoholic fatty liver disease[J]. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23169196.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3598_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","volume":"16","author":"MJ Perugorria","year":"2019","unstructured":"Perugorria MJ, Olaizola P, Labiano I, et al. Wnt-beta-catenin signaling in liver development, health and disease[J]. Nat Rev Gastroenterol Hepatol. 2019;16(2):121\u201336. https:\/\/doi.org\/10.1038\/s41575-018-0075-9.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3598_CR37","doi-asserted-by":"publisher","first-page":"110851","DOI":"10.1016\/j.biopha.2020.110851","volume":"132","author":"S He","year":"2020","unstructured":"He S, Tang S. WNT\/beta-catenin signaling in the development of liver cancers[J]. Biomed Pharmacother. 2020;132:110851. https:\/\/doi.org\/10.1016\/j.biopha.2020.110851.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"3598_CR38","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","volume":"71","author":"J Calderaro","year":"2019","unstructured":"Calderaro J, Ziol M, Paradis V, et al. Molecular and histological correlations in liver cancer[J]. J Hepatol. 2019;71(3):616\u201330. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.001.","journal-title":"J Hepatol"},{"key":"3598_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154515","author":"C Xu","year":"2022","unstructured":"Xu C, Xu Z, Zhang Y, et al. beta-Catenin signaling in hepatocellular carcinoma[J]. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI154515.","journal-title":"J Clin Invest"},{"issue":"5","key":"3598_CR40","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cmet.2019.01.002","volume":"29","author":"AO Adebayo Michael","year":"2019","unstructured":"Adebayo Michael AO, Ko S, Tao J, et al. Inhibiting glutamine-dependent mTORC1 activation ameliorates liver cancers driven by beta-catenin mutations[J]. Cell Metab. 2019;29(5):1135\u201350. https:\/\/doi.org\/10.1016\/j.cmet.2019.01.002.","journal-title":"Cell Metab"},{"issue":"11","key":"3598_CR41","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1074\/jbc.RA118.004984","volume":"294","author":"C Kolliopoulos","year":"2019","unstructured":"Kolliopoulos C, Raja E, Razmara M, et al. Transforming growth factor beta (TGFbeta) induces NUAK kinase expression to fine-tune its signaling output[J]. J Biol Chem. 2019;294(11):4119\u201336. https:\/\/doi.org\/10.1074\/jbc.RA118.004984.","journal-title":"J Biol Chem"},{"issue":"1","key":"3598_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"Peng D, Fu M, Wang M, et al. Targeting TGF-beta signal transduction for fibrosis and cancer therapy[J]. Mol Cancer. 2022;21(1):104. https:\/\/doi.org\/10.1186\/s12943-022-01569-x.","journal-title":"Mol Cancer"},{"issue":"1","key":"3598_CR43","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","volume":"9","author":"A Chakravarthy","year":"2018","unstructured":"Chakravarthy A, Khan L, Bensler NP, et al. TGF-beta-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure[J]. Nat Commun. 2018;9(1):4692. https:\/\/doi.org\/10.1038\/s41467-018-06654-8.","journal-title":"Nat Commun"},{"issue":"7791","key":"3598_CR44","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-019-1897-5","volume":"577","author":"J Su","year":"2020","unstructured":"Su J, Morgani SM, David CJ, et al. TGF-beta orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1[J]. Nature. 2020;577(7791):566\u201371. https:\/\/doi.org\/10.1038\/s41586-019-1897-5.","journal-title":"Nature"},{"issue":"4","key":"3598_CR45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/path.5680","volume":"254","author":"EH Budi","year":"2021","unstructured":"Budi EH, Schaub JR, Decaris M, et al. TGF-beta as a driver of fibrosis: physiological roles and therapeutic opportunities[J]. J Pathol. 2021;254(4):358\u201373. https:\/\/doi.org\/10.1002\/path.5680.","journal-title":"J Pathol"},{"key":"3598_CR46","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1200\/CCI.20.00077","volume":"4","author":"M Farha","year":"2020","unstructured":"Farha M, Jairath NK, Lawrence TS, et al. Characterization of the tumor immune microenvironment identifies M0 macrophage-enriched cluster as a poor prognostic factor in hepatocellular carcinoma[J]. JCO Clin Cancer Inform. 2020;4:1002\u201313. https:\/\/doi.org\/10.1200\/CCI.20.00077.","journal-title":"JCO Clin Cancer Inform"},{"key":"3598_CR47","doi-asserted-by":"publisher","first-page":"803037","DOI":"10.3389\/fimmu.2021.803037","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang C, Ma C, Gong L, et al. Macrophage polarization and its role in liver disease[J]. Front Immunol. 2021;12:803037. https:\/\/doi.org\/10.3389\/fimmu.2021.803037.","journal-title":"Front Immunol"},{"issue":"15","key":"3598_CR48","doi-asserted-by":"publisher","first-page":"16295","DOI":"10.1002\/cam4.6242","volume":"12","author":"C Wang","year":"2023","unstructured":"Wang C, Shen N, Guo Q, et al. YAP\/STAT3 inhibited CD8(+) T cells activity in the breast cancer immune microenvironment by inducing M2 polarization of tumor-associated macrophages[J]. Cancer Med. 2023;12(15):16295\u2013309. https:\/\/doi.org\/10.1002\/cam4.6242.","journal-title":"Cancer Med"},{"key":"3598_CR49","doi-asserted-by":"publisher","first-page":"888713","DOI":"10.3389\/fimmu.2022.888713","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao J, Liang Y, Wang L. shaping polarization of tumor-associated macrophages in cancer immunotherapy[J]. Front Immunol. 2022;13:888713. https:\/\/doi.org\/10.3389\/fimmu.2022.888713.","journal-title":"Front Immunol"},{"issue":"43","key":"3598_CR50","doi-asserted-by":"publisher","first-page":"17253","DOI":"10.1073\/pnas.1308887110","volume":"110","author":"FY McWhorter","year":"2013","unstructured":"McWhorter FY, Wang T, Nguyen P, et al. Modulation of macrophage phenotype by cell shape[J]. Proc Natl Acad Sci USA. 2013;110(43):17253\u20138. https:\/\/doi.org\/10.1073\/pnas.1308887110.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3598_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s11658-019-0164-y","volume":"24","author":"L Zhu","year":"2019","unstructured":"Zhu L, Chen L. Progress in research on paclitaxel and tumor immunotherapy[J]. Cell Mol Biol Lett. 2019;24:40. https:\/\/doi.org\/10.1186\/s11658-019-0164-y.","journal-title":"Cell Mol Biol Lett"},{"issue":"11","key":"3598_CR52","doi-asserted-by":"publisher","first-page":"9171","DOI":"10.1126\/sciadv.abl9171","volume":"8","author":"X Cao","year":"2022","unstructured":"Cao X, Chen J, Li B, et al. Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy[J]. Sci Adv. 2022;8(11):9171. https:\/\/doi.org\/10.1126\/sciadv.abl9171.","journal-title":"Sci Adv"},{"key":"3598_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007253","author":"YN Wang","year":"2023","unstructured":"Wang YN, Wang YY, Wang J, et al. Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes anti-tumor immune response[J]. J Immunother Cancer. 2023. https:\/\/doi.org\/10.1136\/jitc-2023-007253.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"3598_CR54","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1038\/s41401-021-00835-w","volume":"43","author":"FS Zhang","year":"2022","unstructured":"Zhang FS, He QZ, Qin CH, et al. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review[J]. Acta Pharmacol Sin. 2022;43(9):2173\u201390. https:\/\/doi.org\/10.1038\/s41401-021-00835-w.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"3598_CR55","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s10557-021-07239-2","volume":"36","author":"L Wang","year":"2022","unstructured":"Wang L, Peng Y, Song L, et al. Colchicine-containing nanoparticles attenuates acute myocardial infarction injury by inhibiting inflammation[J]. Cardiovasc Drugs Ther. 2022;36(6):1075\u201389. https:\/\/doi.org\/10.1007\/s10557-021-07239-2.","journal-title":"Cardiovasc Drugs Ther"},{"key":"3598_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225650","author":"L Wordeman","year":"2021","unstructured":"Wordeman L, Vicente JJ. Microtubule targeting agents in disease: classic drugs, novel roles[J]. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13225650.","journal-title":"Cancers"},{"issue":"1","key":"3598_CR57","doi-asserted-by":"publisher","first-page":"HEP11","DOI":"10.2217\/hep-2019-0001","volume":"6","author":"JL Raoul","year":"2019","unstructured":"Raoul JL, Frenel JS, Raimbourg J, et al. Current options and future possibilities for the systemic treatment of hepatocellular carcinoma[J]. Hepat Oncol. 2019;6(1):HEP11. https:\/\/doi.org\/10.2217\/hep-2019-0001.","journal-title":"Hepat Oncol"},{"issue":"2","key":"3598_CR58","doi-asserted-by":"publisher","first-page":"188638","DOI":"10.1016\/j.bbcan.2021.188638","volume":"1876","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Wang S, Cai J, et al. The progress of immune checkpoint therapy in primary liver cancer[J]. Biochim Biophys Acta Rev Cancer. 2021;1876(2):188638. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188638.","journal-title":"Biochim Biophys Acta Rev Cancer"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03598-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03598-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03598-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T16:22:48Z","timestamp":1738254168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03598-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["3598"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03598-y","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,20]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}